Incidence and predictors of fragility fracture in postmenopausal rheumatoid arthritis patients receiving oral bisphosphonates: a longitudinal observational study
Abstract Background Although many studies have reported the predictors of fractures in patients with rheumatoid arthritis (RA) who are not receiving anti-osteoporotic treatments or who are receiving unspecified treatments, studies focusing on the predictors of fracture in patients with RA who are cu...
Main Authors: | Yuji Kishimoto, Yoshihiro Kato, Manami Uemura, Koji Kuranobu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-02-01
|
Series: | BMC Rheumatology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s41927-021-00243-x |
Similar Items
-
Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates
by: Tetsuya Kaneko, et al.
Published: (2019-10-01) -
Epidemiological aspects of rheumatoid arthritis patients affected by oral bisphosphonate-related osteonecrosis of the jaws
by: Conte-Neto Nicolau, et al.
Published: (2012-03-01) -
Antiresorptive activity of denosumab in the treatment of osteoporosis in patients with rheumatoid arthritis
by: Nadezhda Y. Banshchikova, et al.
Published: (2018-12-01) -
OSTEOPOROSIS IN A MALE PATIENT WITH RHEUMATOID ARTHRITIS (A CLINICAL CASE)
by: A. A. Muradyants, et al.
Published: (2014-11-01) -
OSTEOPOROSIS IN A MALE PATIENT WITH RHEUMATOID ARTHRITIS (A CLINICAL CASE)
by: A. A. Muradyants, et al.
Published: (2014-11-01)